New Rochelle, NY, October 13, 2017-Researchers have reported a method for successfully removing the cellular material from whole human livers while retaining the organ's three-dimensional structure and extracellular matrix (ECM) components. They further demonstrated the feasibility of reseeding these liver scaffolds with human cells, providing proof-of-concept for a nondestructive decellularization approach to generating bioengineered liver grafts for transplantation. The study is published in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Stem Cells and Development website.
Luc van der Laan, Jeroen de Jonge, and colleagues from Erasmus MC-University Medical Center, Rotterdam, The Netherlands, coauthored the article entitled "Decellularization of Whole Human Liver Grafts Using Controlled Perfusion for Transplantable Organ Bioscaffolds". They describe a decellularization protocol carried out by controlled machine perfusion that uses non-iogenic detergents to remove the existing liver cells, leaving intact the ECM, which is critically important for successful reseeding of the liver scaffold and eventual organ regeneration. The researchers showed that while the protocol completely removed cellular DNA and RNA, it left a bioscaffold that was non-toxic for newly introduced cells and maintained the anatomical characteristics of the native liver's microvascular and biliary drainage networks.
"The shortage of available transplant donors for patients with end stage liver disease makes clear the need for alternate therapeutic modalities. Here, the researchers present proof of concept for the successful decellularization and subsequent recellularization of the human liver," says Editor-in-Chief Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
About the Journal
Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cellular Reprogramming, Tissue Engineering, and Human Gene Therapy. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.